medlr news AstraZeneca India Receives CDSCO Approval for Advanced Breast Cancer Therapy AstraZeneca India secures CDSCO approval for Trastuzumab deruxtecan, expanding its use in treating HER2-low and ultralow metastatic breast cancer in adults, offering renewed hope for patients after endocrine therapy resistance.
News AstraZeneca Introduces Trastuzumab Deruxtecan for HER2-Positive Breast Cancer in India "AstraZeneca's introduction of Trastuzumab Deruxtecan in India presents a significant milestone in treating HER2-positive breast cancer. Developed collaboratively with Daiichi Sankyo.
News AstraZeneca Unveils AI-Powered Lung Cancer Screening in Karnataka AstraZeneca collaborates with the Karnataka government to introduce AI-powered lung cancer screening using Qure.ai's chest X-ray system. This initiative aims to identify up to 29 lung diseases in a single X-ray, enabling early detection.
